Kristina Zalants

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Left Ventricular

Duchenne Muscular Dystrophy

Top Venues

Stem cell reviews and reports

Archivum immunologiae et therapiae experimentalis

This page only lists publications with an associated author ORCID identifier.

Publications

Maria Siemionow, Katarzyna Budzynska, Kristina Zalants, Paulina Langa, Sonia Brodowska, Krzysztof Siemionow, Ahlke Heydemann
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model. Biomedicines 12 (3) (2024)
Maria Siemionow, Katarzyna Budzynska, Kristina Zalants, Paulina Langa, Sonia Brodowska, Krzysztof Siemionow, Ahlke Heydemann
Amelioration of Morphological Pathology in Cardiac, Respiratory, and Skeletal Muscles Following Intraosseous Administration of Human Dystrophin Expressing Chimeric (DEC) Cells in Duchenne Muscular Dystrophy Model. Biomedicines 12 (3) (2024)
Maria Siemionow, Paulina Langa, Sonia Brodowska, Katarzyna Kozlowska, Kristina Zalants, Katarzyna Budzynska, Ahlke Heydemann
Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy. Stem cell reviews and reports 18 (8) (2022)
Maria Siemionow, Paulina Langa, Sonia Brodowska, Katarzyna Kozlowska, Kristina Zalants, Katarzyna Budzynska, Ahlke Heydemann
Correction: Long-Term Protective Effect of Human Dystrophin Expressing Chimeric (DEC) Cell Therapy on Amelioration of Function of Cardiac, Respiratory and Skeletal Muscles in Duchenne Muscular Dystrophy. Stem cell reviews and reports (2022)
Maria Siemionow, Sonia Brodowska, Paulina Langa, Kristina Zalants, Katarzyna Kozlowska, Wictoria Grau-Kazmierczak, Ahlke Heydemann
Long-Term Biodistribution and Safety of Human Dystrophin Expressing Chimeric Cell Therapy After Systemic-Intraosseous Administration to Duchenne Muscular Dystrophy Model. Archivum immunologiae et therapiae experimentalis 70 (1) (2022)